EC
Eric Crombez
Director

Eric Crombez insider trades: Abeona Therapeutics (ABEO) stock sales

Director, Abeona Therapeutics Last trade May 15, 2026 18 Form 4 filings
$396K
Sold, last 12 months
4 sales
$0
Bought, last 12 months
0 buys
10
Open-market trades
since 2024
3
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Eric reports to the SEC

Open-market buys and sales

10 trades reported on SEC Form 4, newest first

DateStockTypeValue
May 15, 2026ABEO↓ Sell$145K
May 5, 2026RARE↓ Sell$9K
Mar 2, 2026RARE↓ Sell$160K
Feb 2, 2026ABEO↓ Sell$83K
Aug 14, 2025ABEO↓ Sell$33K
May 5, 2025RARE↓ Sell$29K
Mar 3, 2025RARE↓ Sell$377K
May 2, 2024RARE↓ Sell$15K
Apr 18, 2024RARE↓ Sell$6K
Mar 1, 2024RARE↓ Sell$67K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other ABEO insiders

Open-market trades in the last 12 months

About Eric Crombez's insider trades

Eric Crombez is a director at Abeona Therapeutics (ABEO). Since Mar 1, 2024, Eric has reported no open-market purchases and 10 sales worth $923K on SEC Form 4. In the last 12 months: 4 sales ($396K).

Their filings also include grants and awards (10 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ABEO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.